Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ohki Healthcare Holdings Co.,Ltd. (3417.T)
Tokyo, JP
Ohki Healthcare Holdings Co.,Ltd., a venerable Japanese enterprise founded in Tokyo in 1658, operates with a broad and diversified portfolio across numerous sectors. The company primarily engages in the import, export, distribution, and sale of an extensive range of products. Its vast offerings encompass pharmaceuticals, over-the-counter drugs, medical devices, veterinary medicines, health foods, and cosmetics, alongside a wide array of daily necessities. The company also handles specialized items such as poisons and deleterious substances, reagents, measuring instruments, optical instruments, electrical products, and communication equipment. Additionally, Ohki Healthcare Holdings supplies a comprehensive selection of consumer goods, including dairy products, pet supplies, textiles, sanitary items, beauty and health equipment, sports and leisure gear, nursing care products, toys, stationery, household goods, groceries, food additives, alcoholic beverages, grains, salt, and tobacco. Its reach extends to agricultural and industrial markets, providing chemicals, fertilizers, pesticides, gardening essentials, and other agricultural supplies. Beyond its significant trading operations, the company is actively involved in manufacturing various products, including pharmaceuticals, quasi-drugs, cosmetics, health foods, killing agents, medical and sanitary items, medical skin care products, soft drinks, environmental conservation products, and diverse general merchandise. Furthermore, Ohki Healthcare Holdings offers a suite of services such as warehousing, the development and management of information processing systems, distribution system equipment, and software development. The company also manages retail pharmacies and drug stores, provides medical prescription dispensing services, operates in the nursing care sector, and facilitates license application agency services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.65% | -15.96% | -15.58% | -15.65% | -19.90% | -19.62% | +7.22% | +30.48% | -8.19% | +145.81% | +471.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Pharmaceuticals: +7.8%+3.1% Q1'26: +1.1% (vs Q1'25)
-
EPS growth Medical - Pharmaceuticals: +20.2%-49.3% Q1'26: -119.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%-0.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Pharmaceuticals: +6.8%+0.2% Q1'26: -0.8% (vs Q1'25)
-
ROIC Medical - Pharmaceuticals: +6.1%+0.9% Q1'26: -5.7% (vs Q1'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×13.35× Q1'26: -7.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 3/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.00% | 8.0K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hidemasa Matsui | President & Representative Director | — | male |
| Hideo Matsui | Executive Chairman | — | male |
| Yoshinobu Ube | Senior MD & Representative Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3417.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
